Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,644 | -5,007 | -15,451 | -10,471 | -6,224 |
| Depreciation Amortization | 10 | 5 | 20 | 15 | 10 |
| Accounts receivable | -33 | -76 | 428 | 120 | 83 |
| Other Working Capital | 1,508 | 540 | -48 | -2,142 | -3,105 |
| Other Operating Activity | 311 | 168 | -63 | 111 | 50 |
| Operating Cash Flow | $-7,849 | $-4,370 | $-15,114 | $-12,368 | $-9,186 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -15 | -15 | -5 |
| Other Investing Activity | 0 | 0 | 53 | 53 | 25 |
| Investing Cash Flow | $N/A | $N/A | $38 | $38 | $20 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 15 | 15 | 15 |
| Debt Repayment | N/A | N/A | -8 | -8 | -8 |
| Common Stock Issued | 7,147 | 3,742 | N/A | N/A | N/A |
| Financing Cash Flow | $7,147 | $3,742 | $7 | $7 | $7 |
| Beginning Cash Position | 1,543 | 1,543 | 16,613 | 16,613 | 16,613 |
| End Cash Position | 842 | 915 | 1,543 | 4,290 | 7,453 |
| Net Cash Flow | $-702 | $-628 | $-15,069 | $-12,323 | $-9,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,849 | -4,370 | -15,114 | -12,368 | -9,186 |
| Capital Expenditure | N/A | N/A | -15 | -15 | -5 |
| Free Cash Flow | -7,849 | -4,370 | -15,129 | -12,383 | -9,191 |